9/8/25 20:07 | 9/4/25 | MLYS | Health | Drug | Pharmaceutical Preparations | Akkaraju Srinivas | CA | D | | P | 15,000 | 25.50 | 0 | 588 | 10 | 6,263 | I | | | | | | | | | | | | | | |
9/8/25 17:59 | 9/4/25 | MLYS | Health | Drug | Pharmaceutical Preparations | Ra Capital Management, L.P. | MA | D | | P | 30,000 | 25.50 | 0 | 1,176 | 19 | 7,324 | I | | | | | | | | | | | | | | |
4/25/25 19:01 | 3/13/25 | MLYS | Health | Drug | Pharmaceutical Preparations | Slingsby Brian Taylor | WA | DT | | P | 3,500 | 13.50 | 0 | 259 | 3 | 8,904 | I | | | | | | | | | | | | | | |
3/17/25 21:05 | 3/13/25 | MLYS | Health | Drug | Pharmaceutical Preparations | Samsara Biocapital Gp, LLC | CA | T | | P | 8,100 | 13.50 | 0 | 600 | 12 | 5,675 | I | | | | | | | | | | | | | | |
3/17/25 21:04 | 3/13/25 | MLYS | Health | Drug | Pharmaceutical Preparations | Akkaraju Srinivas | CA | D | | P | 8,100 | 13.50 | 0 | 600 | 12 | 5,675 | I | | | | | | | | | | | | | | |
3/17/25 19:56 | 3/13/25 | MLYS | Health | Drug | Pharmaceutical Preparations | Ra Capital Management, L.P. | MA | D | | P | 17,500 | 13.50 | 0 | 1,296 | 27 | 6,147 | I | | | | | | | | | | | | | | |
2/14/24 21:06 | 2/12/24 | MLYS | Health | Drug | Pharmaceutical Preparations | Samsara Biocapital Gp, LLC | CA | T | | P | 7,500 | 13.50 | 0 | 556 | 12 | 5,075 | I | | | | | | | | | | | | | | |
11/27/23 16:01 | 11/22/23 | MLYS | Health | Drug | Pharmaceutical Preparations | Congleton Jon | PA | DO | CEO | P | 25 | 5.97 | 0 | 4 | 0 | 1,049 | D | | | | | | | | | | | | | | |
9/8/23 08:49 | 9/6/23 | MLYS | Health | Drug | Pharmaceutical Preparations | Congleton Jon | PA | DO | CEO | P | 27 | 12.08 | 0 | 2 | 0 | 1,045 | D | | | | | | | | | | | | | | |
8/21/23 16:03 | 8/17/23 | MLYS | Health | Drug | Pharmaceutical Preparations | Congleton Jon | PA | DO | CEO | P | 27 | 12.10 | 0 | 2 | 0 | 1,043 | D | | | | | | | | | | | | | | |
8/11/23 19:11 | 8/11/23 | MLYS | Health | Drug | Pharmaceutical Preparations | Congleton Jon | PA | DO | CEO | P | 26 | 12.89 | 0 | 2 | 0 | 1,040 | D | | | | | | | | | | | | | | |